Wintest
6721
Showcase
3909
Beauty Kadan Holdings
3041
Cybozu
4776
KODAMA CHEMICAL INDUSTRY
4222
(Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -0.56%65.62B | -13.38%260.59B | -5.10%63.13B | -14.87%65.6B | -16.27%65.87B | -16.03%65.99B | -0.06%300.83B | -21.05%66.52B | 0.45%77.07B | 9.69%78.67B |
Cost of revenue | 2.67%56.53B | -14.01%220.27B | -4.44%54.33B | -14.23%55.55B | -17.78%55.33B | -18.11%55.06B | -0.23%256.14B | -20.21%56.85B | -1.63%64.77B | 9.97%67.3B |
Gross profit | -16.82%9.09B | -9.77%40.33B | -8.96%8.8B | -18.28%10.05B | -7.28%10.54B | -3.74%10.93B | 0.94%44.69B | -25.65%9.67B | 13.01%12.3B | 8.09%11.37B |
Operating expense | 10.35%5.27B | 4.48%19.57B | -2.00%4.95B | 7.81%5B | 8.48%4.86B | 4.35%4.77B | 2.16%18.73B | -2.98%5.05B | 5.75%4.64B | 0.74%4.48B |
Staff costs | ---- | ---- | ---- | ---- | ---- | 5.11%2.16B | ---- | ---- | 8.47%2.18B | -1.32%2.17B |
Depreciation and amortization | ---- | ---- | ---- | ---- | ---- | -13.29%450M | ---- | ---- | -15.17%425M | -18.00%401M |
-Depreciation | ---- | ---- | ---- | ---- | ---- | 19.02%413M | ---- | ---- | 19.31%383M | 13.27%350M |
-Amortization | ---- | ---- | ---- | ---- | ---- | -78.49%37M | ---- | ---- | -76.67%42M | -71.67%51M |
Other operating expenses | ---- | ---- | ---- | ---- | ---- | 8.16%2.16B | ---- | ---- | 8.43%2.03B | 8.54%1.91B |
Operating profit | -37.87%3.83B | -20.06%20.76B | -16.55%3.86B | -34.06%5.05B | -17.53%5.68B | -9.20%6.16B | 0.08%25.96B | -40.75%4.62B | 17.91%7.66B | 13.47%6.89B |
Net non-operating interest income (expenses) | 58.23%-33M | 54.06%-266M | 62.75%-38M | 43.97%-79M | 58.58%-70M | 52.69%-79M | 20.90%-579M | 39.29%-102M | 29.15%-141M | 11.05%-169M |
Non-operating interest income | 36.36%165M | 78.42%521M | 50.98%154M | 41.56%109M | 132.20%137M | 124.07%121M | 129.92%292M | 168.42%102M | 208.00%77M | 103.45%59M |
Non-operating interest expense | -1.00%198M | -9.64%787M | -5.88%192M | -13.76%188M | -9.21%207M | -9.50%200M | 1.40%871M | -0.97%204M | -2.68%218M | 4.11%228M |
Net investment income | -33.10%287M | 22.24%786M | 153.00%53M | 504.76%254M | -87.28%50M | 39.29%429M | 1,430.95%643M | 62.96%-100M | -65.00%42M | 702.04%393M |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
Income from associates and other participating interests | -59.74%31M | -74.86%92M | -11.54%23M | -121.67%-13M | -96.27%5M | -47.26%77M | 35.06%366M | -10.34%26M | 160.87%60M | -19.28%134M |
Special income (charges) | 266.19%509M | -187.98%-366M | -997.44%-428M | 13.33%-13M | -146.15%-64M | -71.98%139M | 408.15%416M | 0.00%-39M | 0.00%-15M | -26M |
Less:Restructuring and mergern&acquisition | ---509M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Less:Other special charges | ---- | 137.50%156M | 458.97%218M | -13.33%13M | 146.15%64M | 71.98%-139M | -408.15%-416M | 0.00%39M | 0.00%15M | --26M |
Less:Write off | ---- | --210M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
Other non-operating income (expenses) | -83.33%-121M | -127.60%-61M | -1,150.00%-105M | -51.72%28M | -10.87%82M | -208.20%-66M | 32.34%221M | 135.71%10M | -19.44%58M | 4.55%92M |
Income before tax | -32.40%4.5B | -22.53%20.94B | -23.88%3.36B | -31.80%5.23B | -22.27%5.69B | -12.68%6.66B | 5.78%27.03B | -39.69%4.42B | 17.91%7.67B | 19.86%7.31B |
Income tax | -56.45%888M | -20.78%6.58B | -41.28%832M | -27.39%2.01B | -17.07%1.7B | -1.59%2.04B | 11.74%8.31B | -15.60%1.42B | 31.08%2.77B | 10.69%2.05B |
Net income | -21.81%3.61B | -23.31%14.36B | -15.69%2.53B | -34.28%3.22B | -24.32%3.98B | -16.81%4.62B | 3.33%18.72B | -46.85%3B | 11.55%4.9B | 23.86%5.26B |
Net income continuous operations | -21.79%3.62B | -23.31%14.36B | -15.66%2.53B | -34.30%3.22B | -24.30%3.99B | -16.81%4.62B | 3.33%18.72B | -46.86%3B | 11.57%4.9B | 23.86%5.26B |
Noncontrolling interests | -24.14%638M | -27.53%2.25B | -30.73%399M | -51.48%425M | -32.91%583M | 7.68%841M | -14.10%3.1B | -60.33%576M | 7.48%876M | 15.41%869M |
Net income attributable to the company | -21.30%2.98B | -22.48%12.11B | -12.12%2.13B | -30.56%2.79B | -22.59%3.4B | -20.82%3.78B | 7.68%15.62B | -42.16%2.43B | 12.50%4.02B | 25.68%4.4B |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | -21.30%2.98B | -22.48%12.11B | -12.12%2.13B | -30.56%2.79B | -22.59%3.4B | -20.82%3.78B | 7.68%15.62B | -42.16%2.43B | 12.50%4.02B | 25.68%4.4B |
Gross dividend payment | ||||||||||
Basic earnings per share | -21.41%119.45 | -22.59%486.21 | -12.26%85.56 | -30.66%112.11 | -22.70%136.55 | -20.94%151.99 | 7.55%628.08 | -42.25%97.51 | 12.31%161.67 | 25.43%176.65 |
Diluted earnings per share | -21.41%119.45 | -22.59%486.21 | -12.26%85.56 | -30.66%112.11 | -22.70%136.55 | -20.94%151.99 | 7.55%628.08 | -42.25%97.51 | 12.32%161.67 | 25.46%176.65 |
Dividend per share | 0 | -22.75%146 | -32.48%79 | 0 | -6.94%67 | 0 | 46.51%189 | 24.47%117 | 0 | 105.71%72 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |